ST. JOSEPHS HOSPITAL OF BUCKHANNON
1. Target Overview & Investment Thesis
ST. JOSEPHS HOSPITAL OF BUCKHANNON is a 25-bed suburban community hospital in UPSHUR, WV with $101.4M in net patient revenue and a 15.7% operating margin. The hospital serves a payer mix of 31.3% Medicare, 3.0% Medicaid, and 65.7% commercial.
Thesis: Turnaround. Our ML models identify $7.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 15.7% to 23.1% (+736bps).
| Net Revenue HCRIS | $101.4M |
| Current EBITDA COMPUTED | $16.0M |
| Operating Margin COMPUTED | 15.7% |
| Occupancy HCRIS | 47.1% |
| Revenue / Bed COMPUTED | $4.1M |
| Net-to-Gross HCRIS | 45.3% |
| Distress Probability ML | 45.9% |
2. Market Context & Competitive Position
WV has 62 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 15.7% places it above the state median. Among 30 size-comparable peers (12-50 beds), the median margin is 0.8%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (12-50), prioritizing same-state peers. 30 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| ST. JOSEPHS HOSPITAL OF BUCKHA (Target) | WV | 25 | $101.4M | 15.7% |
| JEFFERSON MEMORIAL HOSPITAL | WV | 25 | $85.5M | 9.7% |
| POTOMAC VALLEY HOSPITAL | WV | 25 | $69.5M | 16.2% |
| BOONE MEMORIAL HOSPITAL | WV | 25 | $61.8M | -12.0% |
| SUMMERSVILLE REGIONAL MED CENT | WV | 25 | $60.6M | 0.3% |
| ST FRANCIS HOSPITAL | WV | 40 | $58.5M | 30.5% |
| ROANE GENERAL HOSPITAL | WV | 25 | $48.9M | -13.1% |
| JACKSON GENERAL HOSPITAL | WV | 25 | $47.9M | 12.6% |
| GRANT MEMORIAL HOSPITAL | WV | 25 | $47.8M | -2.8% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.1M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $2.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $2.0M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.2M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $65K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $16.0M |
| + RCM Uplift | +$7.5M |
| Pro Forma EBITDA | $23.4M |
| Current Margin | 15.7% |
| Pro Forma Margin | 23.1% |
| WC Released (1x) | $3.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $24.5M | $179.9M | 7.33x | 48.9% |
| Base (11x exit) | 10.0x | 11.0x | $24.5M | $205.8M | 8.39x | 53.0% |
| Bull Case | 9.0x | 11.0x | $22.1M | $238.5M | 10.80x | 60.9% |
| Bull (12x exit) | 9.0x | 12.0x | $22.1M | $266.7M | 12.07x | 64.6% |
| Bear Case | 11.0x | 10.0x | $27.0M | $134.6M | 4.99x | 37.9% |
| Bear (11x exit) | 11.0x | 11.0x | $27.0M | $156.8M | 5.81x | 42.2% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 30 hospitals with 12-50 beds
- Same-state prioritization (n=31)
- Comp margins: P25=-12.8% / P50=0.8% / P75=10.1%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.